Karen Harrington‐Brock

Author

Environmental Protection Agency

Also Known As

K Harrington-Brock, K. Harrington-Brock, Karen Harrington-Brock, Karen Harrington‐Brock

Publications

Citations

H-Index

Concepts

All Affiliations

Environmental Protection Agency Research Triangle Park Foundation Dow Chemical (United States)Covance (United Kingdom)National Institute of Environmental Health Sciences

About

Karen Harrington‐Brock is an author at Environmental Protection Agency specializing in medicine, immunology, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	792
2	Health Sciences	1	1	65
3	Natural Sciences	1	1	36
4	Allergy	1	1	14
5	Biochemistry	1	1	162

Karen Harrington‐Brock

Publications

948

Citations

H-Index

Page 1

	Year	Citations
Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations Andrew D. Kligerman, Carolyn L. Doerr, Alan H. Tennant, Environmental and Molecular Mutagenesis GeneticsImmunologyMolecular BiologyPathologyEscherichia Coli	2003	200
Relative genotoxic potency of arsenic and its methylated metabolites Martha M. Moore, Karen Harrington‐Brock, Carolyn L. Doerr Mutation Research/Reviews in Mutation Research BiochemistryMedicineMetalloid ContaminationRelative Genotoxic PotencyPoisoning	1997	162
V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans James C. Fuscoe, Lisa J. Zimmerman, Karen Harrington‐Brock, Mutation Research Letters ImmunogeneticsJ Recombinase-mediated DeletionImmune Cell DevelopmentGeneticsLymphocyte Development	1992	70
Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000 Martha M. Moore, Masamitsu Honma, Julie Clements, Environmental and Molecular Mutagenesis Genotoxicity Test ProceduresImmunotoxicologyPathologyToxicology TestingImmunophenotyping	2002	65
Genotoxicity in mouse lymphoma cells of chemicals capable of Michael addition Kerry L. Dearfield, Karen Harrington‐Brock, Carolyn L. Doerr, Mutagenesis	1991	57
Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK+/− −3.7.2C mouse lymphoma cells Karen Harrington‐Brock, Carolyn L. Doerr, Martha M. Moore Mutation Research/Genetic Toxicology and Environmental Mutagenesis Disinfection By-productsChloral HydrateTrichloroacetic AcidMedicineImmunology	1998	55
Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) <i>in vivo</i> and <i>in vitro</i> Lorraine C. Backer, James W. Allen, Karen Harrington‐Brock, Mutagenesis ImmunologyCell DeathImmunotherapyMouse Bone MarrowMyeloid Neoplasia	1990	51
Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup report Martha M. Moore, Masamitsu Honma, Julie Clements, Environmental and Molecular Mutagenesis Lymphoid NeoplasiaOncologyRelative Cloning EfficiencyGenetic DisorderMedicine	2000	48
Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes James C. Fuscoe, Lisa J. Zimmerman, Karen Harrington‐Brock, Mutation Research Letters Hprt LocusAutoimmune DiseaseT-regulatory CellImmunologyHematology	1992	46
Identification and chromosomal assignment of two heterozygous mutations in the <i>Trp53</i> gene in L5178Y\<i>Tk</i> <sup>+\−</sup>-3.7.2C mouse lymphoma cells L. Scott Clark, Daniel W. Hart, Patrick J. Vojta, Mutagenesis	1998	41

Page 1